Literature DB >> 8545110

The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRb-mediated growth arrest or apoptosis.

R Hansen1, R Reddel, A Braithwaite.   

Abstract

To investigate the mechanisms by which p53 suppresses cell transformation, we used the simian virus 40 (SV40) large T antigen (LTag), the adenovirus E1a proteins, and an activated ras protein (EJ-ras), to examine different pathways of transformation for their susceptibility to suppression by p53: While p53 can suppress transformation by various oncoproteins, we have shown that it is unable to suppress the transformation of rat embryo fibroblasts (REFs) by LTag. Interestingly, the function of LTag which enables it to overcome the antiproliferative effects of p53 is not the binding and inactivation of p53, but the binding and inactivation of the pRb family of proteins. This observation indicates that pRb mediates a suppressive effect of p53 on cell transformation. We have also observed that in contrast to LTag, both E1a and EJ-ras cause transformation-related events which are susceptible to suppression by p53. Further studies have revealed that cells expressing E1a are susceptible to p53-mediated apoptosis, while cells expressing EJ-ras are susceptible to p53-induced growth inhibition. We therefore propose that p53 suppresses transformation either by arresting cell growth (mediated by pRb in late G1) or by inducing apoptosis, with the mechanism being determined by the transforming oncoprotein(s).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545110

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

Review 1.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.

Authors:  J E Hundley; S K Koester; D A Troyer; S G Hilsenbeck; M A Subler; J J Windle
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

3.  In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.

Authors:  Y Hosokawa; A Papanikolaou; R D Cardiff; K Yoshimoto; M Bernstein; T C Wang; E V Schmidt; A Arnold
Journal:  Transgenic Res       Date:  2001-10       Impact factor: 2.788

4.  p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53.

Authors:  E Gottlieb; M Oren
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

5.  Simian virus 40 small t antigen activates the carboxyl-terminal transforming p53-binding domain of large T antigen.

Authors:  J Zerrahn; F Tiemann; W Deppert
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.

Authors:  A Mezzelani; L Alasio; C Bartoli; M G Bonora; M A Pierotti; F Rilke; S Pilotti
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.